title: Clinical and technical requirements for proton treatment planning of ocular diseases. The SERAG (South Europe Radiotherapy Group).
authors.affiliation: Centre Antoine-Lacassagne-Cyclotron Biomédical, Nice, France.
authors.forename: P
authors.initials: P
authors.lastname: Chauvel
authors.forename: W
authors.initials: W
authors.lastname: Sauerwein
authors.forename: N
authors.initials: N
authors.lastname: Bornfeld
authors.forename: W
authors.initials: W
authors.lastname: Friedrichs
authors.forename: N
authors.initials: N
authors.lastname: Brassart
authors.forename: A
authors.initials: A
authors.lastname: Courdi
authors.forename: J
authors.initials: J
authors.lastname: Hérault
authors.forename: J P
authors.initials: JP
authors.lastname: Pignol
authors.forename: P Y
authors.initials: PY
authors.lastname: Bondiau
authors.forename: G
authors.initials: G
authors.lastname: Malandain
mesh_terms: D003230:Conjunctival Neoplasms / Q000175:diagnosis / Q000532:radiotherapy; D004307:Dose-Response Relationship, Radiation; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008545:Melanoma / Q000175:diagnosis / Q000532:radiotherapy*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D011237:Predictive Value of Tests; D061766:Proton Therapy; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014604:Uveal Neoplasms / Q000175:diagnosis / Q000532:radiotherapy*; D011522:Protons
chemical_list: D011522:Protons